SCHEMBL7184986

SCHEMBL7184986

CCOc1ccc(C=CC(=O)c2ccc(C(=O)N(C)C)cc2)c(OCC)c1

nearest known ligand 0.61

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 2/20 0.61
CYP1B1 Q16678 2/20 0.61
TNFRSF1A P19438 1/20 0.53
MAOB P27338 6/20 0.52
MAPT P10636 5/20 0.52
LMNA P02545 4/20 0.52
SMN1; SMN2 Q16637 3/20 0.52
ATM Q13315 1/20 0.52
KEAP1 Q14145 1/20 0.52
NFE2L2 Q16236 1/20 0.52
DPP4 P27487 2/20 0.51
KDM4E B2RXH2 2/20 0.50
ALDH1A1 P00352 2/20 0.50
MAOA P21397 1/20 0.50
HPGD P15428 1/20 0.49
ABCG2 Q9UNQ0 1/20 0.49
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7184981 1.00 CYP1A1 (0.61) CYP1A1CYP1B1TNFRSF1AMAOBMAPT
SCHEMBL9115243 0.90 CYP1A1 (0.69) CYP1A1CYP1B1TNFRSF1AMAOBMAPT
SCHEMBL9115237 0.90 CYP1A1 (0.69) CYP1A1CYP1B1TNFRSF1AMAOBMAPT
SCHEMBL7185724 0.88 CYP1A1 (0.62) CYP1A1CYP1B1TNFRSF1AMAPTLMNA
SCHEMBL7177347 0.88 CYP1A1 (0.57) CYP1A1CYP1B1TNFRSF1AMAPTLMNA
SCHEMBL9115417 0.86 CYP1A1 (0.71) CYP1A1CYP1B1TNFRSF1AMAOBMAPT
SCHEMBL7177114 0.86 MAOB (0.66) CYP1A1CYP1B1TNFRSF1AMAOBMAPT
SCHEMBL7177119 0.86 MAOB (0.66) CYP1A1CYP1B1TNFRSF1AMAOBMAPT
SCHEMBL9115423 0.86 CYP1A1 (0.71) CYP1A1CYP1B1TNFRSF1AMAOBMAPT
SCHEMBL7179900 0.85 CYP1A1 (0.64) CYP1A1CYP1B1TNFRSF1AMAOBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
US-5985935-A PARASITICIDES OR BACTERICIDES STATENS SERUMINSTITUT (DK) 1999-11-16 US disclosed